Find information on thousands of medical conditions and prescription drugs.

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is an umbrella term for a group of respiratory tract diseases that are characterised by airflow obstruction or limitation. It is usually caused by tobacco smoking. more...

Home
Diseases
A
B
C
Angioedema
C syndrome
Cacophobia
Café au lait spot
Calcinosis cutis
Calculi
Campylobacter
Canavan leukodystrophy
Cancer
Candidiasis
Canga's bead symptom
Canine distemper
Carcinoid syndrome
Carcinoma, squamous cell
Carcinophobia
Cardiac arrest
Cardiofaciocutaneous...
Cardiomyopathy
Cardiophobia
Cardiospasm
Carnitine transporter...
Carnitine-acylcarnitine...
Caroli disease
Carotenemia
Carpal tunnel syndrome
Carpenter syndrome
Cartilage-hair hypoplasia
Castleman's disease
Cat-scratch disease
CATCH 22 syndrome
Causalgia
Cayler syndrome
CCHS
CDG syndrome
CDG syndrome type 1A
Celiac sprue
Cenani Lenz syndactylism
Ceramidase deficiency
Cerebellar ataxia
Cerebellar hypoplasia
Cerebral amyloid angiopathy
Cerebral aneurysm
Cerebral cavernous...
Cerebral gigantism
Cerebral palsy
Cerebral thrombosis
Ceroid lipofuscinois,...
Cervical cancer
Chagas disease
Chalazion
Chancroid
Charcot disease
Charcot-Marie-Tooth disease
CHARGE Association
Chediak-Higashi syndrome
Chemodectoma
Cherubism
Chickenpox
Chikungunya
Childhood disintegrative...
Chionophobia
Chlamydia
Chlamydia trachomatis
Cholangiocarcinoma
Cholecystitis
Cholelithiasis
Cholera
Cholestasis
Cholesterol pneumonia
Chondrocalcinosis
Chondrodystrophy
Chondromalacia
Chondrosarcoma
Chorea (disease)
Chorea acanthocytosis
Choriocarcinoma
Chorioretinitis
Choroid plexus cyst
Christmas disease
Chromhidrosis
Chromophobia
Chromosome 15q, partial...
Chromosome 15q, trisomy
Chromosome 22,...
Chronic fatigue immune...
Chronic fatigue syndrome
Chronic granulomatous...
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic obstructive...
Chronic renal failure
Churg-Strauss syndrome
Ciguatera fish poisoning
Cinchonism
Citrullinemia
Cleft lip
Cleft palate
Climacophobia
Clinophobia
Cloacal exstrophy
Clubfoot
Cluster headache
Coccidioidomycosis
Cockayne's syndrome
Coffin-Lowry syndrome
Colitis
Color blindness
Colorado tick fever
Combined hyperlipidemia,...
Common cold
Common variable...
Compartment syndrome
Conductive hearing loss
Condyloma
Condyloma acuminatum
Cone dystrophy
Congenital adrenal...
Congenital afibrinogenemia
Congenital diaphragmatic...
Congenital erythropoietic...
Congenital facial diplegia
Congenital hypothyroidism
Congenital ichthyosis
Congenital syphilis
Congenital toxoplasmosis
Congestive heart disease
Conjunctivitis
Conn's syndrome
Constitutional growth delay
Conversion disorder
Coprophobia
Coproporhyria
Cor pulmonale
Cor triatriatum
Cornelia de Lange syndrome
Coronary heart disease
Cortical dysplasia
Corticobasal degeneration
Costello syndrome
Costochondritis
Cowpox
Craniodiaphyseal dysplasia
Craniofacial dysostosis
Craniostenosis
Craniosynostosis
CREST syndrome
Cretinism
Creutzfeldt-Jakob disease
Cri du chat
Cri du chat
Crohn's disease
Croup
Crouzon syndrome
Crouzonodermoskeletal...
Crow-Fukase syndrome
Cryoglobulinemia
Cryophobia
Cryptococcosis
Crystallophobia
Cushing's syndrome
Cutaneous larva migrans
Cutis verticis gyrata
Cyclic neutropenia
Cyclic vomiting syndrome
Cystic fibrosis
Cystinosis
Cystinuria
Cytomegalovirus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Conditions included in this umbrella term are:

  • chronic bronchitis
  • emphysema

Other names

COPD is also known as CORD, COAD, COLD which respectively stand for chronic obstructive respiratory, airways, or lung disease. COPD has been referred to as CAL which stands for chronic airway limitation.

Working definition

COPD is a chronic, progressive disorder related to tobacco abuse and characterized by airways obstruction (FEV1 <80% predicted and FEV1 / VC ratio <70%).

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) defines COPD as "a disease state characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with abnormal inflammatory response of the lungs to noxious particles or gases."

Causes

The main risk factor in the development of COPD is smoking. Approximately 15% of all chronic smokers will develop the disease. In susceptible people, this causes chronic inflammation of the bronchi and eventual airway obstruction. Other etiologies include alpha 1-antitrypsin deficiency (augmented by smoking), byssinosis, and idiopathic disease.

Among people over 70 who have never smoked, women make up 85 percent of those with COPD. This appears to be tied to decreases in estrogen as women age. Female mice that had their ovaries removed to deprive them of estrogen lost 45 percent of their working alveoli from their lungs. Upon receiving estrogen, the mice recovered full lung function. Two proteins that are activated by estrogen play distinct roles in breathing. One protein builds new alveoli, the other stimulates the alveoli to expel carbon dioxide. Loss of estrogen hampered both functions in the test mice. (Massaro & Massaro, 2004).

Progression

COPD is a progressive disease. Obstructive changes in spirometry and decreases in diffusion capacity are typically seen before symptoms occur. Early signs and symptoms are shortness of breath on exertion, recurrent respiratory infections or a morning cough. As the disease continues, the symptoms are seen with increased frequency and severity. In the late stages, the patient often experiences severe cough, constant wheezing, and shortness of breath with minimal exertion or rest. At this late stage, progression to respiratory failure and death is common. Progression is typically caused by the patient's continued exposure to tobacco smoke. Although medications often decrease symptoms, it is not believed that they prevent the progression if the patient continues to smoke.

Read more at Wikipedia.org


[List your site here Free!]


Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Lung Biology in Health and Disease, Volume 183
From CHEST, 4/1/05 by Gabriel Laszlo

Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Lung Biology in Health and Disease, Volume 183. By Nikos M. Siafakis, Nicholas R. Anthonisen, and Dimitris Georgopoulos, eds. New York, NY: Marcel Dekker, 2004; 603 pp; $199.95

The Lung Biology series published by Marcel Dekker covers a wide range of topical issues. Some are collections of illuminating essays aimed at fellow researchers, while others target comprehensive coverage of their theme, in effect addressed "to whom it may concern." No. 183, cast in the latter mold, is a detailed review of the epidemiology, pathology, physiology, presentation, and treatment of acute exacerbations of COPD (AECOPD). This is timely, in view of the current investment of time and effort that at long last is being directed toward the amelioration of this distressing group of conditions. In total, 66 contributors from 10 countries (11, if we count Scotland separately) have written all of 32 chapters. These are headed conventionally: definition, epidemiology, pathology, radiology, and so on.

All hospital physicians know what is meant by acute exacerbations of COPD: patients experience worsening dyspnea and cough and an increase in the volume and purulence of their sputum. These clinical observations were encapsulated in 1987 by Anthonisen et al in the Annals of Internal Medicine, and a universal definition of AECOPD might have resulted from this work. Regrettably, many different definitions have emerged that muddied the waters and made it somewhat difficult to review the AECOPD literature.

The evidence-based answers to many common questions about AECOPD can be found in this book. Do steroids help? (yes); should antibiotics be prescribed? (yes, if the sputum is purulent); do bacterial infections damage the airways permanently? (probably); why does oxygen administration cause Pco2 to rise sometimes? (because it worsens ventilation/perfusion dispersion); does noninvasive positive pressure ventilation have a role? (sometimes). Strikingly, electrolyte and water balance have hardly been investigated since 1980; the causes of edema, the role of comorbid left ventricular dysfunction, and the effects of loop diuretics are still not well studied and are dismissed throughout the book as self-evident.

There is a great deal of thoroughly researched and well-presented material here, and a few contributors allowed their own contribution to shine through, such as Bshouty's description of his informative model of cardiopulmonary interactions. Disappointingly, though, the patients do not emerge from these pages to tell their own stories. A complex organization that cares for AECOPD at home is described in detail, but although it has been imitated widely throughout the world there is no systematic evaluation as yet, nor are we told how these new approaches might be viewed by patients and their caregivers. We are promised an essay on end-of-life planning, but nothing of any human or scientific value is offered. Good qualitative research is rare, but some attempt might have been made to encourage it. Unfortunately, systematic study is hampered by the index, which is rather thin and was not corrected after the final pages of the book were inserted; after about page 100, it is necessary to add 2 to the page number to find a subject.

Much of this material can be found in textbooks covering the whole topic of COPD. Nevertheless, this book provides detailed answers to many of the questions asked by students and generalists who may have to treat patients with AECOPD. Mercifully, guidelines have not dictated the contents, and the book corrects some of the worst features of these, such as the writing out of emphysema and the oversimplification of lung function to FE[V.sub.1] and peak flow. Teachers of respiratory medicine will enjoy seeing the relevant classical literature presented elegantly in a modern context.

Gabriel Laszlo, MD

Bristol, UK

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Chronic obstructive pulmonary disease
Home Contact Resources Exchange Links ebay